GEO for Healthcare: AI Search Strategy for a High-Stakes YMYL Category

Healthcare has gone further into AI search than any other category

Every "GEO for X" vertical we've written faces AI Overviews and chatbot citation to some degree. Healthcare faces it at near-saturation. Google now shows an AI Overview on 89% of healthcare keywords, per BrightEdge's December 2025 tracking snapshot, the highest AI Overview adoption rate of any industry BrightEdge measures, up from 59% in December 2023. On the clinical side specifically, treatment and procedure queries sit at 100% AI Overview coverage, symptom and condition queries at 93%. If you publish anything a patient might search before, during, or after a diagnosis, an AI-generated answer is standing between you and that reader more often than not.

At the same time, this is the most regulated, highest-scrutiny content category on the internet. Google's own quality-rater guidelines single out health information as core "Your Money or Your Life" territory, the category where a wrong or unverifiable answer can cause real harm, and its raters are explicitly told to hold YMYL health content to the strictest E-E-A-T bar it applies to anything. The AI systems trained on that same signal behave the same way: they cite hard, they cite narrow, and they cite whoever already has the deepest, most verifiable clinical authority.

That combination, near-total AI presence plus a citation graph that rewards a small number of institutions with genuine credentials, is why healthcare GEO looks different from every other vertical in this series. You are not competing to get noticed. You are competing against Mayo Clinic.

A note on scope before we go further. This is marketing and AI-visibility strategy, not medical, legal, or compliance advice. Healthcare marketing operates under real regulatory constraints, HIPAA on patient data and testimonials, FTC rules on health claims and substantiation, and state-level medical advertising and licensing board rules that vary by specialty and state, the same way bar advertising rules governed the case-results caveats in our GEO for law firms guide. Nothing here substitutes for review by qualified healthcare compliance counsel before you publish clinical content, patient outcome claims, or anything touching protected health information.

Who's actually getting cited, and why you probably can't out-cite them

Everything-PR's Healthcare Citation Share Index, published June 2026, tested 75-plus consumer, clinician, and procurement-intent queries across ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews, then scored the top 25 healthcare brands by composite citation share (weighted 40% citation frequency, 20% cross-engine breadth, 20% query-type breadth, 15% extractability, 5% crawl access). Mayo Clinic leads at 9.4, ahead of every pharma brand in the index. Cleveland Clinic is second at 7.1, Johns Hopkins third at 6.8. WebMD (5.9), Healthline (5.4), and NIH/MedlinePlus (5.2) round out a top six, then Eli Lilly, Pfizer, Novo Nordisk, and Epic Systems close the top ten. The top 15 brands alone capture roughly 64% of all category citation share.

Mayo Clinic, Cleveland Clinic, and Johns Hopkins together account for about 23.3% of total healthcare citation share, more than the entire pharma category combined, and the index's own explanation is unglamorous but correct: Mayo Clinic and Cleveland Clinic have alternated at #1 on the U.S. News & World Report Best Hospitals ranking for more than 15 consecutive years, a durable, independently-verified authority signal that compounds into every AI engine's retrieval graph. Johns Hopkins hasn't held that #1 spot, but its #3 position in the citation ranking reflects the same kind of standing: one of the country's leading academic medical centers, with a comparable weight of peer-reviewed research and institutional reputation behind it. This isn't a content-marketing win. It's decades of peer-reviewed publication, physician-authored patient education at enormous scale, and an institutional reputation no amount of GEO tactics recreates in a quarter.

The honest strategic conclusion: if you're a specialty clinic, a health-tech company, a pharma brand outside the top tier, or a health information site, going after broad clinical-topic citations head-on against Mayo Clinic is not a realistic goal for most organizations. The viable path is narrower and more specific: defensible topical authority in one condition area or specialty, backed by genuine clinical review, not broad coverage of "healthcare" as a category.

Part 1: E-E-A-T and clinical review aren't optional, they're the entry fee

In most GEO verticals, E-E-A-T signals help. In healthcare, they're closer to a hard requirement. Google's quality-rater guidelines apply their strictest standard to YMYL health content specifically because a wrong answer can cause direct harm, and AI systems built on the same underlying signals inherit that bias toward verifiable expertise.

What this means in practice, at minimum:

• Every clinical page needs a named, credentialed medical reviewer, not a generic "medically reviewed" badge with no attribution. State the reviewer's name, credentials, and specialty, and link to a real bio page.
• Review dates need to be visible and current. Clinical guidance changes; a symptom or treatment page reviewed three years ago and never revisited is a liability, not an asset.
• Author bios need actual medical credentials where the content is clinical, not marketing-team bylines. If a non-clinician writes the draft, the reviewing physician's name still needs to be the one that carries authority on the page.
• Sourcing needs to trace to primary literature, professional guidelines (AMA, specialty-society guidance, CDC, NIH), or peer-reviewed studies, cited specifically, not "studies show" with no link.

None of this is new SEO advice. What's changed is the stakes: AI systems now surface this content directly as an answer, without a click, to a person who may be making a real health decision off it. A content-review process for healthcare content should treat inaccuracy the way a hospital treats a medication error, as a serious failure to catch before it ships, not after.

Part 2: Structured data for medical content

Schema is a floor requirement here, not a differentiator, because AI systems and Google's own health-content classifiers lean on it to understand what a page actually is. At minimum:

{
  "@context": "https://schema.org",
  "@type": "MedicalWebPage",
  "about": {
    "@type": "MedicalCondition",
    "name": "Condition Name",
    "code": {
      "@type": "MedicalCode",
      "code": "ICD-10 code",
      "codingSystem": "ICD-10"
    }
  },
  "reviewedBy": {
    "@type": "Person",
    "name": "Dr. Reviewer Name",
    "jobTitle": "Physician specialty",
    "hasCredential": {
      "@type": "EducationalOccupationalCredential",
      "credentialCategory": "Board Certification"
    }
  },
  "lastReviewed": "2026-08-01",
  "audience": {
    "@type": "PatientAudience"
  }
}

Pair MedicalWebPage with MedicalCondition, MedicalProcedure, or Drug schema depending on content type, and use MedicalOrganization at the site level with medicalSpecialty populated accurately, not a generic list of every service line. Person schema on physician bio pages should carry hasCredential and board-certification detail the same way attorney bio pages carry bar admissions in the legal GEO playbook, that's the asset a directory profile or third-party listing can't replicate, because only the organization can publish the full, current, first-person version of a physician's credentials.

Part 3: The local-versus-informational split that changes your whole strategy

This is the most useful, least obvious finding in BrightEdge's data, and it should directly shape where you invest.

The practical split: if you're a local practice or clinic whose growth depends on people finding and booking with you nearby, your local SEO investment, Google Business Profile, local pack rankings, review volume, still does the actual work, per BrightEdge's own reading of the data. AI Overviews are not intercepting that traffic the way they are on symptom and treatment queries, at least not currently. If you're a health information publisher, a pharma brand, or a health-tech company whose value is clinical or educational content rather than local booking, you're the one competing directly in the near-saturated AI Overview layer, and that's where the E-E-A-T and schema work in Parts 1 and 2 matters most.

Treating these as the same problem is the mistake. A local urgent-care chain optimizing clinical blog content for AI Overview capture is solving a problem it doesn't have, while a health information site pouring budget into local pack rankings is ignoring the channel that actually carries its traffic.

Part 4: Build narrow, defensible topical authority instead of broad coverage

Given that Mayo Clinic, Cleveland Clinic, and Johns Hopkins already hold roughly a quarter of all healthcare citation share on the strength of decades of institutional authority, the realistic play for almost every other organization is depth in one lane, not breadth across the category.

Concretely, that means:

• Pick one specialty or condition area where you have genuine clinical depth, real physicians, real case volume, real outcomes data, not the widest set of service lines you can list. A specialty clinic covering one condition area in full depth, with named specialists and current, reviewed content, is more citable within that lane than a broad health system's thin coverage of the same topic.
• Build the full content set for that lane, not one page per topic. Symptom explainers, treatment-option comparisons, procedure walkthroughs, FAQ content answering the exact question-style prompts patients type into ChatGPT and Perplexity, all reviewed and dated, all cross-linked so the topic reads as a coherent body of work rather than scattered pages.
• Credential every piece of that content visibly. This is where a narrow player can genuinely compete with a large health system: a small group of named, board-certified specialists writing and reviewing deep content in their exact specialty is a stronger authority signal, within that lane, than a generalist page from a much larger but less specific source.
• Publish primary clinical data where you have it, outcomes, case series, protocol comparisons. This is the closest equivalent to the case-results pages that drive legal AI citations, specific, factual, verifiable content that retrieval systems favor over general marketing language, again always subject to compliance review on what can be claimed and how.

This won't get a specialty clinic cited on broad queries like "how to lower blood pressure." It's a realistic path to being the cited source on the specific procedure, condition, or treatment pathway where the organization's actual clinical expertise lives, and pursuing that narrow, defensible lane is worth more than diluting effort trying to compete broadly against three institutions with a 15-year head start.

Measuring healthcare AI visibility

90-day roadmap

Month 1: E-E-A-T and schema foundation

• Audit every clinical page for named, credentialed reviewer attribution and current review dates
• Implement MedicalWebPage, MedicalCondition/MedicalProcedure, and MedicalOrganization schema across clinical content
• Build or update Person schema with hasCredential detail on every physician and specialist bio page
• Run manual query sampling across ChatGPT, Perplexity, Gemini, and Google AI Overviews for your top clinical terms to establish a citation baseline

Month 2: Choose and build the narrow lane

• Identify the one specialty or condition area with the strongest genuine clinical depth and named-specialist coverage
• Build or rebuild the full content set for that lane: symptom, treatment, procedure, and FAQ content, all clinically reviewed
• Confirm HIPAA, FTC, and state-specific medical advertising rules with compliance counsel before publishing any outcomes or patient-experience content
• If local-intent traffic matters to the business, keep that investment in local SEO fundamentals separate from the AI Overview content work, per the local-versus-informational split in Part 3

Month 3: Measure and expand within the lane

• Re-run the query sampling from Month 1 and track citation gains specifically within the chosen specialty lane
• Identify any named-but-uncited pattern, where AI mentions a clinician or the organization by name without citing a specific page, and build the linkable asset that closes that gap
• Expand content depth within the same lane before considering a second specialty area
• Set a recurring quarterly cadence for clinical review currency and schema maintenance; stale medical content is a compliance risk as well as a citation risk

Frequently asked questions

Why does healthcare have the highest AI Overview coverage of any industry?

BrightEdge's tracking shows Google expanding AI Overview presence in healthcare from 59% of keywords in December 2023 to 89% by December 2025, the highest of any industry BrightEdge measures. Clinical content specifically, treatment, procedure, and symptom queries, is now at 93-100% coverage. Google appears to treat healthcare as a category where AI-generated summaries help users navigate a genuinely complex system, while simultaneously excluding AI Overviews entirely from certain sensitive categories like self-harm, crisis, and addiction-related queries.

Can a small clinic or health-tech company realistically compete with Mayo Clinic for AI citations?

Not on broad clinical-topic queries, and it's worth being honest about that rather than promising otherwise. Mayo Clinic, Cleveland Clinic, and Johns Hopkins hold roughly 23.3% of total healthcare citation share between them, built on more than 15 years of top hospital rankings and enormous, physician-authored content libraries. The realistic strategy for most organizations is narrow topical authority in one specialty or condition area with genuine clinical depth, not broad category coverage.

Why did Google remove AI Overviews from "near me" healthcare searches?

BrightEdge's data shows local, provider-intent healthcare queries went from 100% AI Overview presence in 2023 to 0% by December 2025, a complete reversal, while informational clinical queries moved sharply in the opposite direction. The most likely read is that Google decided local, transactional healthcare intent, finding and booking a nearby provider, is better served by traditional local results (Maps, local pack, organic listings) than by an AI-generated summary, while informational and clinical queries are treated as a better fit for AI Overviews. For a local practice, this means local SEO fundamentals still carry the acquisition channel, not AI Overview optimization.

What's the minimum schema markup healthcare content needs for AI citation?

MedicalWebPage at the page level, paired with MedicalCondition, MedicalProcedure, or Drug schema depending on the content type, plus MedicalOrganization at the site level with medicalSpecialty populated accurately. Physician and specialist bio pages should carry Person schema with hasCredential detail covering board certification. None of this guarantees a citation on its own, but it's close to table stakes for AI systems to correctly classify and trust medical content in the first place.

Is this guide medical or legal advice?

No. This is AI-visibility and content-strategy guidance for healthcare marketing teams. It is not medical, legal, or compliance advice, and healthcare marketing is subject to HIPAA, FTC health-claim substantiation rules, and state-level medical advertising and licensing-board rules that vary significantly by state and specialty. Any clinical content, patient outcome claim, or content touching protected health information should go through qualified compliance counsel before publication.

Sources: OpenAI, "AI as a Healthcare Ally: How Americans are navigating the system with ChatGPT," January 2026, BrightEdge, "Healthcare and AI Overviews: How Google Sharpened Its Approach Over Three Years," 2026, Everything-PR, "The Healthcare Citation Share Index 2026," June 11, 2026